ClinicalTrials.gov is a Web-based resource created as a result of the Food and Drug Administration Modernization Act of 1997 (FDAMA). FDAMA required the U.S. Department of Health and Human Services ...
Concerns have grown tremendously in recent years regarding noncompliance in clinical trial reporting. Shockingly, the National Institutes of Health (NIH) failed to disclose the results of over ...
To keep research teams informed of the latest updates to ClinicalTrials.gov, the University at Buffalo Clinical and Translational Science Institute (CTSI) will be providing news about the ...
Registering your study with ClinicalTrials.gov is a necessary step for investigators to be compliant with regulations. This UB CTSI Educational Modules video provides useful insights to the Protocol ...
The CWRU Quality Improvement Program (QIP) answers many of the frequently asked questions about registering studies on ClinicalTrials.gov. If your question isn’t addressed here, please email us at ...
Time to colonoscopy and insurance status at an FQHC. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a full text component.
ORION CORPORATION INVESTOR NEWS 21 NOVEMBER 2023 at 08:30 EET Phase 3 Clinical Trials with ODM-208 (MK-5684) posted to ClinicalTrials.gov database Two new Phase 3 clinical trials to evaluate the ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する